Literature DB >> 3491681

Inhibition of in vitro LAK generation by OK-432.

M Yagita, E A Grimm.   

Abstract

The present study was designed to investigate the in vitro effect of OK-432 on interleukin-2-(IL-2) induced lymphokine activated killer (LAK) generation, and especially to test whether OK-432 can substitute for IL-2 or act in synergism with IL-2 for activation of cytotoxic lymphocytes. Surprisingly, our results showed that the addition of OK-432 to 4-day LAK activation cultures significantly inhibited both the generation of cytotoxic effectors to the natural killer (NK) resistant Daudi cell line and the proliferative responses of lymphocytes in a dose dependent manner. The inhibition of activation was total at 0.5 KE/ml of OK-432, a dose which was still effective in augmenting NK activity against K562. The addition of penicillin G potassium (PCGk), which is contained in OK-432 at a concentration of 134,700 units/mg of dried cocci, to the LAK culture system also inhibited LAK generation at equivalent concentrations as contained in the OK-432 preparation. This inhibition of LAK generation by OK-432 was significantly eliminated by dialysis of OK-432. These results indicated that the inhibition of LAK generation was partly due to PCGk contained in the OK-432 preparation, and that OK-432 did not act synergistically with IL-2 in standard LAK activation systems.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491681     DOI: 10.1007/BF00205651

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  27 in total

1.  Cytolytic T lymphocyte effector function requires plasma membrane chloride flux.

Authors:  L S Gray; J H Russell
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

2.  Inhibitory effect of a streptococcal preparation (OK-432) on the nucleic acid synthesis in tumor cells in vitro.

Authors:  T Ono; S Kurata; K Wakabayashi; Y Sugawara; M Saito
Journal:  Gan       Date:  1973-02

3.  Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.

Authors:  S Rosenberg
Journal:  J Natl Cancer Inst       Date:  1985-10       Impact factor: 13.506

4.  Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes.

Authors:  M Saito; T Ebina; M Koi; T Yamaguchi; Y Kawade; N Ishida
Journal:  Cell Immunol       Date:  1982-03-15       Impact factor: 4.868

5.  Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.

Authors:  A Uchida; M Micksche
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

6.  Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432.

Authors:  T Kawaguchi; M Suematsu; H M Koizumi; H Mitsui; S Suzuki; T Matsuno; H Ogawa; K Nomoto
Journal:  Immunopharmacology       Date:  1983-10

7.  Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.

Authors:  K Oshimi; S Kano; F Takaku; K Okumura
Journal:  J Natl Cancer Inst       Date:  1980-12       Impact factor: 13.506

8.  Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.

Authors:  A Uchida; M Micksche; T Hoshino
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.

Authors:  A Uchida; M Micksche
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  2 in total

1.  Anti-tumor effect of intravesical instillation of OK432 against rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.

Authors:  H Tsujihashi; H Matsuda; S Uejima; T Akiyama; T Kurita
Journal:  Urol Res       Date:  1990

2.  Leukoregulin up-regulation of tumor cell sensitivity to natural killer and lymphokine-activated killer cell cytotoxicity.

Authors:  P M Furbert-Harris; C H Evans
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.